Acta Scientific Paediatrics (ISSN: 2581-883X)

Research Article Volume 5 Issue 1

Economic Analysis of Covid-19 Diagnostic Kits in India

Jitendar K Sharma1, Umesh Gupta2, Greeshma Gopalan3, Keerthan RM3 and Kavita Kachroo4*

1MD & CEO/ ED, Kalam Institute of Health Technology, Andhra Pradesh Med Tech Zone, Visakhapatnam, India
2Professor, Head of Mats School of Business Studies, MATS Institute of Management and Entrepreneurship, Bangalore, India
3Scientist -A, Kalam Institute of Health Technology, Andhra Pradesh Med Tech Zone, Visakhapatnam, India 4Scientist -D, Kalam Institute of Health Technology, Andhra Pradesh Med Tech Zone, Visakhapatnam, India

*Corresponding Author: Kavita Kachroo, Scientist -D, Kalam Institute of Health Technology, Andhra Pradesh Med Tech Zone, Visakhapatnam, India.

Received: November 22, 2021; Published: December 29, 2021


Introduction: Ever since the first case was reported in December, in China, Coronavirus disease 2019 (COVID-19) has spread over 218 countries and the casualty prediction of the third wave in India. Making it an absolute necessity for a rapid and accurate detection and diagnosis of the infection for prevention and containment of the disease. Molecular testing (RT-PCR) is considered to be the gold standard for COVID-19 diagnosis is considered accurate.

Methods: The primary COVID-19 diagnosis is done by Polymerase Chain Reaction (PCR) testing. The most common method used for identifying the genetic material from the SARS-CoV-2 is the real-time polymerase chain reaction RT-PCR. A decision analytical model was prepared for RT-PCR testing for COVID-19 diagnosis by selecting three Made in India diagnostic kits (RT-PCR-X, Y and Z) using Tree Age Pro software.

Results: From the economic evaluation, NMB (Net Monitory Benefit) for RT-PCR Y being ₹ 45,43,740 higher and is the most cost-effective intervention as it saves more money compared to other interventions per DALY averted.

Conclusion: Incremental cost-effectiveness ratio (ICER) was calculated, and it is identified that RT-PCR Y is cost effective at ₹ 850 per DALY averted.


Keywords: Cost-effectiveness; COVID-19; Real-time Polymerase Chain Reaction; RT-PCR Kits


  1. Goudouris Ekaterini. “Laboratory Diagnosis of COVID-19”. Jornal de Pediatria 97 (2020).
  2. “COVIDINDIA.ORG Open Testing Data - Google Sheets” (2021).
  3. “WHO Coronavirus Disease (COVID-19) Dashboard” (2021).
  4. “COVID-19 Diagnostics in Context”. Science Translational Medicine (2021).
  5. Carter Linda J., et al. “Assay Techniques and Test Development for COVID-19 Diagnosis”. ACS Central Science5 (2020): 591-605.
  6. Brooks Zoe and Saswati Das. “COVID-19 Testing – Impact of Prevalence, Sensitivity, and Specificity on Patient Risk and Cost”. American Journal of Clinical Pathology 5 (2020): 575-584.
  7. Romero-Alvarez Daniel., et al. “<p>Cycle Threshold Values in the Context of Multiple RT-PCR Testing for SARS-CoV-2</P>“. Risk Management and Healthcare Policy 14 (2021): 1311-1317.
  8. DeArmond Megan., et al. “Diagnostic Accuracy of Rapid Antigen Tests for COVID-19 Compared to the Viral Genetic Test in Adults: A Systematic Review Protocol”. JBI Evidence Synthesis5 (2021): 1148-1156.
  9. “Coronavirus Disease 2019 Testing Basics”. FDA (2021).
  10. Jo Min Woo., et al. “The Burden of Disease Due to COVID-19 in Korea Using Disability-Adjusted Life Years”. Journal of Korean Medical Science21 (2020): e199.
  11. “Home - TreeAge Software” (2021).
  12. Srinivisan R. “Health care in india-vision 2020 issues and prospects”.


Citation: Jitendar K Sharma., et al. “ Economic Analysis of Covid-19 Diagnostic Kits in India”. Acta Scientific Paediatrics 5.1 (2022): 02-08.


Copyright: © 2022 Jitendar K Sharma., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor1.197

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US